Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.
about
Aggregatibacter actinomycetemcomitans: virulence of its leukotoxin and association with aggressive periodontitisActeoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS productionRevisiting the Role of Interleukin-1 Pathway in Osteoarthritis: Interleukin-1α and -1β, and NLRP3 Inflammasome Are Not Involved in the Pathological Features of the Murine Menisectomy Model of Osteoarthritis.Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells.Peroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3Osteoclasts: New InsightsNotch signaling promotes osteoclast maturation and resorptive activity.The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis.IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).Role of Regulators of G Protein Signaling Proteins in Bone Physiology and Pathophysiology.Osteoclasts-Key Players in Skeletal Health and Disease.Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fracturesCombination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-κB, ERK and JNK signaling pathways.Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis.Cellular and Molecular Pathways Leading to External Root Resorption.Five in one therapy for graded treatment of haemophilic arthritis.CCAAT/Enhancer-binding Protein α (C/EBPα) Is Important for Osteoclast Differentiation and Activity.Atorvastatin inhibits osteoclast differentiation by suppressing NF-κB and MAPK signaling during IL-1β-induced osteoclastogenesis.C/EBPα is Regulated by the RANK Cytoplasmic IVVY535-538 Motif and Stimulates Osteoclastogenesis more Strongly than c-Fos.Dry Extract of Matricaria recutita L. (Chamomile) Prevents Ligature-Induced Alveolar Bone Resorption in Rats via Inhibition of Tumor Necrosis Factor-α and Interleukin-1β.Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro Osteoclast Differentiation in Arthritis study.Regulation of Osteoclast Differentiation by Cytokine Networks.A comprehensive overview on osteoporosis and its risk factors
P2860
Q27022924-316B948F-5601-44E2-9438-AA7AF50CE410Q28535889-E64E7272-4348-4AB2-860D-27A42C1698F2Q33790090-65F0A587-E944-4BCC-9B1B-97CB718F6A25Q33916514-52372990-66AE-4537-9C4C-3E7E750578D5Q34545945-7895388E-3876-49DD-A9A0-45DBF182F8C7Q34729815-F7117CA6-EA99-4DEF-99C1-6D0298D5BDF3Q35755039-5D5B7C99-3B1C-4188-8931-1CACCD240A8BQ36047882-08B074D5-3300-41F7-A00F-A079A15E307FQ36093022-6451B14E-6F83-419A-B614-B9047E5C392BQ36444288-D92BBF11-7A01-4E25-8EF9-BEAFCB71BFE9Q36756644-9073586C-F858-4091-BD0B-CCE312B9213DQ37036135-8B25965A-2997-4F4B-B3A7-7499551B242CQ37101614-E5B867EF-A4DD-4217-9AD3-1285A926A85CQ37609556-7D21ACD8-B0C0-4DAE-8EE1-13C9D139BE7BQ38752770-EC3DD295-EA0E-451C-90B3-EE0B641D0594Q38997942-72E8B984-1993-4AED-A648-038B4AC31FDAQ39186314-21D9FD50-947E-4951-9962-F26EC3F16A5AQ42175353-DD72D11A-5DB0-4872-BC6C-E5155037F17FQ47407845-3621A683-CCB0-4533-98B9-DDD3F1F6F946Q47419391-82226FCF-C12F-4BA2-862F-9459F1E08124Q53801281-E6CAACD3-B759-4915-9FF9-9F53FE81A913Q54288752-184AA5C2-0023-48BB-8A43-2511271B23CBQ55226585-7712BF2E-DAFF-40E6-9CCB-F5AF4367BBF2Q59125691-DDCFE1D6-73F0-44B8-B2A4-407C6982C168
P2860
Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Molecular basis of requirement ...... 1-mediated osteoclastogenesis.
@ast
Molecular basis of requirement ...... 1-mediated osteoclastogenesis.
@en
type
label
Molecular basis of requirement ...... 1-mediated osteoclastogenesis.
@ast
Molecular basis of requirement ...... 1-mediated osteoclastogenesis.
@en
prefLabel
Molecular basis of requirement ...... 1-mediated osteoclastogenesis.
@ast
Molecular basis of requirement ...... 1-mediated osteoclastogenesis.
@en
P2093
P2860
P356
P1476
Molecular basis of requirement ...... 1-mediated osteoclastogenesis
@en
P2093
Jianzhong Liu
Joel Jules
Ping Zhang
Suzanne M Michalek
Zhenqi Shi
P2860
P304
15728-15738
P356
10.1074/JBC.M111.296228
P407
P577
2012-03-13T00:00:00Z